Register Now

The healthcare landscape is changing.  Providers are faced with implementation of the FDA’s Unique Device Identification (UDI). The UDI rule was driven by patient advocates due to adverse event reporting, recalls, and more recently Meaningful Use, to name a few. Soon genome therapy will drive the methods and products to treat patients.  Metadata is another consideration in this paradigm shift.  This webinar will explain what healthcare providers need to do to meet the new and future demands of patient care.

Objectives:
  • Define the UDI ruling and the anticipated health benefits
  • Describe the various reports that support the use of the UDI
  • Describe how the use of the UDI will change the future of healthcare
  • Understand how this program will drive change management

About the Speakers:
Jay Crowley
Jay

Vice President of Unique Device Identification Solutions Jay was Senior Advisor for Patient Safety in the Food and Drug Administration’s Center for Devices and Radiological Health. Jay developed the framework and authored key requirements for the FDA’s Unique Device Identification system.

Jean Sargent
Jean Sargent

Vice President of Healthcare Strategy and Implementation at USDM Life Sciences She has over 36 years of experience in central service/materials and supply chain management. Jean has been actively involved with education over the last fifteen years as a speaker, educator, and writer/editor. Jean actively participates in many activities related to the healthcare supply chain to improve upon use of industry standards such as UDI to improve patient safety.

Want our experts to work on your project?

Take the first step towards creating more value with USDM today.

Connect Now

We use cookies to understand how you use our site and improve your experience. This includes personalizing content and advertising. Learn more.